Global Sexually Transmitted Diseases (STD) Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 217852
  • calendar_today Published On: Nov, 2019
  • file_copy Pages: 107
  • list Pharmaceuticals and Healthcare

Scope of the Report:

The global Sexually Transmitted Diseases (STD) Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sexually Transmitted Diseases (STD) Testing.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Sexually Transmitted Diseases (STD) Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sexually Transmitted Diseases (STD) Testing market by product type and applications/end industries.

Market Segment by Companies, this report covers

ROCHE HOLDINGS

ABBOTT LABORATORIES

BECTON DICKINSON

BIOMERIEUX

AFFYMETRIX

HOLOGIC

DIASORIN

DANAHER

ORASURE

BIO-RAD LABORATORIES

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Chlamydia

Syphilis

Gonorrhea

Herpes Simplex Virus

Human Papilloma Virus

Human Immunodeficiency Virus

Others

Market Segment by Applications, can be divided into

Laboratory Testing

Point of Care (POC) Testing

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Sexually Transmitted Diseases (STD) Testing Market Overview

1.1 Product Overview and Scope of Sexually Transmitted Diseases (STD) Testing

1.2 Classification of Sexually Transmitted Diseases (STD) Testing by Types

1.2.1 Global Sexually Transmitted Diseases (STD) Testing Revenue Comparison by Types (2019-2024)

1.2.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Types in 2018

1.2.3 Chlamydia

1.2.4 Syphilis

1.2.5 Gonorrhea

1.2.6 Herpes Simplex Virus

1.2.7 Human Papilloma Virus

1.2.8 Human Immunodeficiency Virus

1.2.9 Others

1.3 Global Sexually Transmitted Diseases (STD) Testing Market by Application

1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Laboratory Testing

1.3.3 Point of Care (POC) Testing

1.4 Global Sexually Transmitted Diseases (STD) Testing Market by Regions

1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Sexually Transmitted Diseases (STD) Testing Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Sexually Transmitted Diseases (STD) Testing Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexually Transmitted Diseases (STD) Testing Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Sexually Transmitted Diseases (STD) Testing Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexually Transmitted Diseases (STD) Testing Status and Prospect (2014-2024)

1.5 Global Market Size of Sexually Transmitted Diseases (STD) Testing (2014-2024)

2 Company Profiles

2.1 ROCHE HOLDINGS

2.1.1 Business Overview

2.1.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.2 ABBOTT LABORATORIES

2.2.1 Business Overview

2.2.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.3 BECTON DICKINSON

2.3.1 Business Overview

2.3.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.4 BIOMERIEUX

2.4.1 Business Overview

2.4.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.5 AFFYMETRIX

2.5.1 Business Overview

2.5.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.6 HOLOGIC

2.6.1 Business Overview

2.6.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.7 DIASORIN

2.7.1 Business Overview

2.7.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.8 DANAHER

2.8.1 Business Overview

2.8.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 DANAHER Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.9 ORASURE

2.9.1 Business Overview

2.9.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ORASURE Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

2.10 BIO-RAD LABORATORIES

2.10.1 Business Overview

2.10.2 Sexually Transmitted Diseases (STD) Testing Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2017-2018)

3 Global Sexually Transmitted Diseases (STD) Testing Market Competition, by Players

3.1 Global Sexually Transmitted Diseases (STD) Testing Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Sexually Transmitted Diseases (STD) Testing Players Market Share

3.2.2 Top 10 Sexually Transmitted Diseases (STD) Testing Players Market Share

3.3 Market Competition Trend

4 Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions

4.1 Global Sexually Transmitted Diseases (STD) Testing Revenue and Market Share by Regions

4.2 North America Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

4.3 Europe Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

4.5 South America Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

5 North America Sexually Transmitted Diseases (STD) Testing Revenue by Countries

5.1 North America Sexually Transmitted Diseases (STD) Testing Revenue by Countries (2014-2019)

5.2 USA Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

5.3 Canada Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

5.4 Mexico Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

6 Europe Sexually Transmitted Diseases (STD) Testing Revenue by Countries

6.1 Europe Sexually Transmitted Diseases (STD) Testing Revenue by Countries (2014-2019)

6.2 Germany Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

6.3 UK Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

6.4 France Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

6.5 Russia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

6.6 Italy Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Countries

7.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Countries (2014-2019)

7.2 China Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

7.3 Japan Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

7.4 Korea Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

7.5 India Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

8 South America Sexually Transmitted Diseases (STD) Testing Revenue by Countries

8.1 South America Sexually Transmitted Diseases (STD) Testing Revenue by Countries (2014-2019)

8.2 Brazil Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

8.3 Argentina Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

8.4 Colombia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Sexually Transmitted Diseases (STD) Testing by Countries

9.1 Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue by Countries (2014-2019)

9.2 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

9.3 UAE Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

9.4 Egypt Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

9.5 Nigeria Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

9.6 South Africa Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2014-2019)

10 Global Sexually Transmitted Diseases (STD) Testing Market Segment by Type

10.1 Global Sexually Transmitted Diseases (STD) Testing Revenue and Market Share by Type (2014-2019)

10.2 Global Sexually Transmitted Diseases (STD) Testing Market Forecast by Type (2019-2024)

10.3 Chlamydia Revenue Growth Rate (2014-2024)

10.4 Syphilis Revenue Growth Rate (2014-2024)

10.5 Gonorrhea Revenue Growth Rate (2014-2024)

10.6 Herpes Simplex Virus Revenue Growth Rate (2014-2024)

10.7 Human Papilloma Virus Revenue Growth Rate (2014-2024)

10.8 Human Immunodeficiency Virus Revenue Growth Rate (2014-2024)

10.9 Others Revenue Growth Rate (2014-2024)

11 Global Sexually Transmitted Diseases (STD) Testing Market Segment by Application

11.1 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2014-2019)

11.2 Sexually Transmitted Diseases (STD) Testing Market Forecast by Application (2019-2024)

11.3 Laboratory Testing Revenue Growth (2014-2019)

11.4 Point of Care (POC) Testing Revenue Growth (2014-2019)

12 Global Sexually Transmitted Diseases (STD) Testing Market Size Forecast (2019-2024)

12.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Forecast (2019-2024)

12.2 Global Sexually Transmitted Diseases (STD) Testing Market Forecast by Regions (2019-2024)

12.3 North America Sexually Transmitted Diseases (STD) Testing Revenue Market Forecast (2019-2024)

12.4 Europe Sexually Transmitted Diseases (STD) Testing Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue Market Forecast (2019-2024)

12.6 South America Sexually Transmitted Diseases (STD) Testing Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Sexually Transmitted Diseases (STD) Testing Picture

Table Product Specifications of Sexually Transmitted Diseases (STD) Testing

Table Global Sexually Transmitted Dis

Please fill the form below, to recieve the report sample


+1